▶Uncommon infection that may be observed at birth or within a week of delivery.
▶Candida albicans (occasionally a non-albicans Candida species) is acquired during passage through a colonized birth canal or by ascending infection before delivery.
▶Eruption presents as papules and pustules superimposed on an erythematous base (Figure 35D.1) or as diffuse erythema with scaling (Figure 35D.2).
▶Presence of papules and pustules on the palms and soles is characteristic.
▶Nail dystrophy with yellow discoloration may be present (Figure 35D.3).
▶Any body surface may be involved.
▶Most full-term neonates experience a benign course, but very low-birth-weight neonates are at higher risk for invasive disease.
Figure 35D.1. Congenital Candidiasis is Characterized by Erythematous Papules, Pustules, and Scaling.

Figure 35D.2. Congenital Candidiasis in a Preterm Neonate with Skin of Color. Note Diffuse Faint Erythema with Marked Scaling and Hyperkeratosis. Such Preterm Neonates Have a Higher Risk for Systemic Dissemination of the Fungal Infection. Reproduced from Jani S, Ariss R, Chawla S. A Preterm Infant with a Characteristic Erythematous and Scaly Rash after Birth. Neoreviews. 2020;21(7):e495e498.

Figure 35D.3. Nail Dystrophy in Congenital Candidiasis. There is Yellow Discoloration, Onycholysis, and Mild Surrounding Paronychia (Ie, Inflammation of Proximal and Lateral Nail Folds).

Look-alikes
In each of the disorders listed herein, a potassium hydroxide preparation would fail to demonstrate the pseudohyphae and spores that would be observed in candidal infection.
| Disorder | Differentiating Features |
|---|---|
| Erythema toxicum |
|
| Transient neonatal pustular melanosis |
|
| Miliaria rubra |
|
| Neonatal cephalic pustulosis (neonatal acne) |
|
| Staphylococcal folliculitis |
|
| Scabies |
|
| Neonatal herpes simplex virus infection |
|
| Infantile acropustulosis |
|
| Incontinentia pigmenti |
|
| Eosinophilic pustular folliculitis |
|
▶The diagnosis is made by performing a potassium hydroxide preparation on skin scrapings (see Figure 35A.2) and fungal culture of specimens from the skin, placenta, or umbilical cord.
▶Topical application of an antifungal agent such as nystatin or clotrimazole.
▶In neonates with diffuse skin involvement, oral fluconazole may accelerate resolution.
▶In the rare patient who has evidence of (or risk factors for) systemic infection, complete evaluation for this possibility and parenteral antifungal therapy are required.
▶The prognosis for term neonates with cutaneous congenital candidiasis is excellent.
▶Low-birth-weight neonates (or those born to mothers with a history of an indwelling device [eg, cervical cerclage, intrauterine device]) are at increased risk for systemic involvement (eg, infection of blood, lungs, central nervous system, urinary tract).
▶Consider consultation by a dermatologist when the diagnosis is in doubt or lesions fail to respond to appropriate therapy.
▶When systemic disease is likely, immediate consultation with a pediatric infectious disease specialist is warranted.